Dechra Pharmaceuticals's competitors

Dechra Pharmaceuticals's competitors include Threshold Pharmaceuticals, Shire, Biogen and PetLife Pharmaceuticals
Add company...
Dechra Pharmaceuticals
A growing global veterinary brand, providing the most appropriate therapeutic solutions and the best support to help you care for companion animals.
Threshold Pharmaceuticals
Threshold Pharmaceuticals is focused on the development of drugs targeting Tumor Hypoxia, a low oxygen condition found in solid tumors.
Shire
Shire is a specialty biopharmaceutical company.
Biogen
Biogen develops, markets and manufactures therapies for people living with serious neurological, autoimmune and rare diseases.
PetLife Pharmaceuticals
PetLife Pharmaceuticals is a registered U.S. Veterinary Pharmaceutical company whose mission is to bring its scientifically proven, bioactive medication and nutraceuticals to the world of veterinary oncology.
Founding Date
Founding Date
1997
Founding Date
2001
Founding Date
1986
Founding Date
1978
Founding Date
2016
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Lostock Gralam, GB HQ
Pointe Claire, CA
Uldum, DK
Torino, IT
Barcelona, ES
Upplands Väsby, SE
Skipton, GB
see more
Locations
South San Francisco, US HQ
Locations
Dublin, IE HQ
Buenos Aires, AR
Sydney, AU
Wien, AT
Bruxelles, BE
Chácara Santo Antonio (Zona Sul), BR
Sofia, BG
see more
Locations
Cambridge, US HQ
Locations
Hancock, US HQ
Employees
Employees
1,3382% increase
Employees
1512% decrease
Employees
23,0444% decrease
Employees
7,3001% decrease
Employees
5
Valuation ($)
Valuation ($)
2.5 b
Valuation ($)
191.2 m
Valuation ($)
50.3 b
Valuation ($)
60.4 b
Valuation ($)
6.3 m
Facebook likes
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
3.1 k
Facebook likes
815
Twitter followers
Twitter followers
2.2 k
Twitter followers
N/A
Twitter followers
6.2 k
Twitter followers
19.4 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
£247.6m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
$15.2b (FY, 2017)
Revenue (est.)
$11.4b (FY, 2016)
Revenue (est.)
N/A
Cost of goods
Cost of goods
£115.1m (FY, 2016)
Cost of goods
N/A
Cost of goods
$4.7b (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
£132.4m (FY, 2016)
Gross profit
N/A
Gross profit
$10.5b (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
£12.5m (FY, 2016)
Net income
($24.1m) (FY, 2016)
Net income
$4.3b (FY, 2017)
Net income
$3.7b (FY, 2016)
Net income
N/A

Operating

Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
7 (FY, 2017)
Phase I Trials Products
4 (FY, 2016)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
10 (FY, 2017)
Phase II Trials Products
10 (FY, 2016)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
15 (FY, 2017)
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Threshold Pharmaceuticals
HQ
South San Francisco, US
Employees
15↓ 12% decrease

Threshold Pharmaceuticals is focused on the development of drugs targeting Tumor Hypoxia, a low oxygen condition found in solid tumors.

View company
Shire
HQ
Dublin, IE
Employees
23,044↓ 4% decrease

Shire is a specialty biopharmaceutical company.

View company
Biogen
HQ
Cambridge, US
Employees
7,300↓ 1% decrease

Biogen develops, markets and manufactures therapies for people living with serious neurological, autoimmune and rare diseases.

View company
PetLife Pharmaceuticals
HQ
Hancock, US
Employees
5

PetLife Pharmaceuticals is a registered U.S. Veterinary Pharmaceutical company whose mission is to bring its scientifically proven, bioactive medication and nutraceuticals to the world of veterinary oncology.

View company